Cargando…
Hydroxychloroquine as a Chemoprophylactic Agent for COVID-19: A Clinico-Pharmacological Review
Hydroxychloroquine has gained much attention as one of the candidate drugs that can be repurposed as a prophylactic agent against SARS-CoV-2, the agent responsible for the COVID-19 pandemic. Due to high transmissibility and presence of asymptomatic carriers and presymptomatic transmission, there is...
Autores principales: | Agarwal, Mudit, Ranjan, Piyush, Baitha, Upendra, Mittal, Ankit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773916/ https://www.ncbi.nlm.nih.gov/pubmed/33390974 http://dx.doi.org/10.3389/fphar.2020.593099 |
Ejemplares similares
-
Association Between Self-Reported Adherence to Preventive Practices and Probability of Turning COVID-19 Positive: A Cross-Sectional Analytical Study
por: Ranjan, Piyush, et al.
Publicado: (2020) -
Formulation Development for Transdermal Delivery of Raloxifene, a Chemoprophylactic Agent against Breast Cancer
por: Vora, Deepal, et al.
Publicado: (2022) -
Development and Validation of a Clinical Symptom-based Scoring System for Diagnostic Evaluation of COVID-19 Patients Presenting to Outpatient Department in a Pandemic Situation
por: Bhattacharya, Aakashneel, et al.
Publicado: (2021) -
Development and validation of a questionnaire for assessing preventive practices and barriers among health care workers in COVID-19 pandemic
por: Agarwal, Ayush, et al.
Publicado: (2021) -
Hydroxychloroquine as Prophylaxis for COVID-19: A Review
por: Monti, Manuela, et al.
Publicado: (2020)